COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,739 Articles (22,502 medRxiv, 8,237 bioRxiv)

Most recent first Previous |  Page 2047: Articles 20461-20470  | Next

SARS-CoV-2 antibody prevalence and symptoms in a local Austrian population
Ladage, D., Hoeglinger, Y., Ladage, D., Adler, C., Yalcin, I., Braun, R.
10.1101/2020.11.03.20219121 — Posted: 2020-11-04
COVID-19 Medical Vulnerability Indicators: A Local Data Model for Equity in Public Health Decision-Making
Ong, P. M., Pech, C., Gutierrez, N. R., Mays, V. M.
10.1101/2020.11.02.20215657 — Posted: 2020-11-04
Rapid SARS-CoV-2 Detection by Carbon Nanotube-Based Near-Infrared Nanosensors
Pinals, R. L., Ledesma, F., Yang, D., Navarro, N., Jeong, S., Pak, J. E., Kuo, L., Chuang, Y.-C., Cheng, Y.-W., Sun, H.-Y., Landry, M. P.
10.1101/2020.11.02.20223404 — Posted: 2020-11-04
Ultra-rapid on-site detection of SARS-CoV-2 infection using simple ATR-FTIR spectroscopy and analysis algorithm: high sensitivity and specificity
Barauna, V. G., Singh, M. N., Barbosa, L. L., Marcarini, W. D., Ribeiro-Rodrigues, R., Vassallo, P. F., Mill, J. G., Warnke, P. H., Martin, F. L.
10.1101/2020.11.02.20223560 — Posted: 2020-11-04
Longitudinal testing for respiratory and gastrointestinal shedding of SARS-CoV-2 in day care centres in Hesse, Germany. Results of the SAFE KiDS Study
Hoehl, S., Kreutzer, E., Schenk, B., Westhaus, S., Foppa, I., Herrmann, E., Ettrich, I., Schaible, A., Rudych, O., Rabenau, H. F., Berger, A., Ciesek, S.
10.1101/2020.11.02.20223859 — Posted: 2020-11-04
Characteristics of those most vulnerable to employment changes during the COVID-19 pandemic: a nationally representative cross-sectional study in Wales
Gray, B. J., Kyle, R. G., Davies, A. R.
10.1101/2020.11.03.20225144 — Posted: 2020-11-04
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study
Barchuk, A., Skougarevskiy, D., Titaev, K., Shirokov, D., Raskina, Y., Novkunkskaya, A., Talantov, P., Isaev, A., Pomerantseva, E., Zhikrivetskaya, S., Barabanova, L., Volkov, V.
10.1101/2020.11.02.20221309 — Posted: 2020-11-04
Preferential observation of large infectious disease outbreaks leads to consistent overestimation of intervention efficacy.
Zelner, J., Masters, N. B., Broen, K., Lofgren, E.
10.1101/2020.11.02.20224832 — Posted: 2020-11-04
Caspases in COVID-19 Disease and Sequela and the Therapeutic Potential of Caspase Inhibitors
Plassmeyer, M., Alpan, O., Corley, M., Lillard, K., Coatney, P., Vaziri, T., Michalski, S., Premeaux, T. A., Pang, A. P. S., Bukhari, Z., Yueng, S. Y., Evering, T., Naughton, G., Latterich, M., Mudd, P. A., Spada, A., Rindone, N., Loizou, D., Ndhlovu, L., Gupta, R.
10.1101/2020.11.02.20223636 — Posted: 2020-11-04
Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco
Pilarowski, G., Lebel, P., Sunshine, S., Liu, J., Crawford, E., Marquez, C., Rubio, L., Chamie, G., Martinez, J., Peng, J., Black, D., Wu, W., Pak, J., Laurie, M. T., Jones, D., Miller, S., Jacobo, J., Rojas, S., Rojas, S., Nakamura, R., Tulier-Laiwa, V., Petersen, M., Havlir, D. V., The CLIAHUB Consortium, , DeRisi, J.
10.1101/2020.11.02.20223891 — Posted: 2020-11-04 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).